As team lead for clinical development and market access at Denmark’s Qmed Consulting, Underbjerg has hands-on experience in helping medtech and medical device companies to navigate the new EU MDR – and the many hurdles that come with it.
The EU MDR is a “good thing,” Underbjerg recently told Medtech Insight. Despite the challenges faced by manufacturers in adhering to the new rules, he is of the view that...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?